Thiogenesis Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	29	34	28	33	23	-
Market Cap Growth	14.69%	22.03%	-17.40%	48.30%	-	-
Enterprise Value	27	30	23	30	21	-
Last Close Price	0.56	0.65	0.60	0.75	0.58	-
PB Ratio	50.54	58.66	8.06	6.05	3.77	-
P/TBV Ratio	50.54	58.66	8.06	6.05	3.77	-
Debt / Equity Ratio	-	-	-	-	-	-0.43
Net Debt / Equity Ratio	-2.81	-2.81	-1.12	-1.28	-1.04	-0.38
Quick Ratio	1.36	1.36	7.06	4.18	20.36	0.18
Current Ratio	1.46	1.46	7.14	4.23	20.48	0.18
Return on Equity (ROE)	-371.31%	-371.31%	-70.25%	-87.95%	-159.48%	-
Return on Assets (ROA)	-159.42%	-159.42%	-39.85%	-48.08%	-38.51%	-738.68%
Return on Capital Employed (ROCE)	-1287.50%	-1287.50%	-104.50%	-94.10%	-33.60%	157.50%
Earnings Yield	-25.58%	-22.04%	-11.39%	-15.15%	-17.41%	-
Buyback Yield / Dilution	-7.11%	-7.11%	-15.93%	-54.71%	-118.86%	-15.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.